Emergent BioSolutions Inc. (EBS) Guidance & Earnings Results
On 2025-10-29 Emergent BioSolutions Inc. raised guidance: "Raising full-year 2025 revenue and profitability…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EBSEmergent BioSolutions Inc.Follow EBS — free
—
Price chart with a free account
- Market cap
- 319.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 29 Oct 25 | Raised | Raising full-year 2025 revenue and profitability guidance · full year |
| 6 Aug 25 | Raised | FY2025 profitability guidance: raising low end/midpoint; revenue guidance not explicitly quantified in excerpt. · full year |
Emergent BioSolutions Inc. — questions
- What guidance did Emergent BioSolutions Inc. give?
- On 2025-10-29: "Raising full-year 2025 revenue and profitability guidance"
- When does Emergent BioSolutions Inc. report earnings?
- Emergent BioSolutions Inc.'s next earnings report is expected on 2026-11-02.
Every figure on this page comes from Emergent BioSolutions Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.